Oct 4 (Reuters) - Johnson & Johnson ( JNJ ) said on Friday it will discontinue its mid-stage field study evaluating the efficacy of its antiviral drug candidate for the prevention of dengue. ...

09:15 AM EDT, 10/04/2024 (MT Newswires) -- DMG Blockchain Solutions Inc. ( DMGGF ) , a vertically integrated blockchain and data center technology company, announced Friday its preliminary Bitcoin operational results for September 2024. Among highlights, DMG cited bitcoin mined of 23 BTC; hashrate of 1.1 EH/s; and bitcoin holdings of 436 BTC. In a hosting update, DMG said it...

09:41 AM EDT, 10/04/2024 (MT Newswires) -- DuPont de Nemours ( DD ) said Friday it has almost doubled its photoresist production capacity at the Sasakami Site in Japan with the opening of a new building called the East Star. The new building features cleanrooms for the production of photoresists, with advanced automation systems implemented to cut contamination risks and...

(Reuters) -Johnson & Johnson ( JNJ ) said on Friday it will discontinue a mid-stage field study evaluating the efficacy of its antiviral drug candidate for the prevention of dengue. The decision to discontinue the study was part of a reprioritization of the company's communicable diseases research and development portfolio, J&J said. In another mid-stage study, six of 10 participants...